Chevli KK, Shore ND, Trainer A, Smith AB, et al. Primary Chemoablation of Low-Grade Intermediate-Risk Non-Muscle-Invasive Bladder Cancer Using UGN-102, A Mitomycin-Containing Reverse Thermal Gel (Optima II): A Phase 2b, Open-Label, Single-Arm Trial. J Urol 2021 Aug 26:101097JU0000000000002186. doi: 10.1097/JU.0000000000002186.
PMID: 34433303